GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sunmax Biotechnology Co Ltd (ROCO:4728) » Definitions » Gross-Profit-to-Asset %

Sunmax Biotechnology Co (ROCO:4728) Gross-Profit-to-Asset % : 84.85% (As of Mar. 2025)


View and export this data going back to 2012. Start your Free Trial

What is Sunmax Biotechnology Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Sunmax Biotechnology Co's annualized Gross Profit for the quarter that ended in Mar. 2025 was NT$1,763 Mil. Sunmax Biotechnology Co's average Total Assets over the quarter that ended in Mar. 2025 was NT$2,078 Mil. Therefore, Sunmax Biotechnology Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 was 84.85%.


Sunmax Biotechnology Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Sunmax Biotechnology Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunmax Biotechnology Co Gross-Profit-to-Asset % Chart

Sunmax Biotechnology Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 56.62 62.81 72.79 34.08 40.88

Sunmax Biotechnology Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70.09 63.75 68.20 -77.74 84.85

Competitive Comparison of Sunmax Biotechnology Co's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Sunmax Biotechnology Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunmax Biotechnology Co's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sunmax Biotechnology Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Sunmax Biotechnology Co's Gross-Profit-to-Asset % falls into.


;
;

Sunmax Biotechnology Co Gross-Profit-to-Asset % Calculation

Sunmax Biotechnology Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=735.153/( (1746.342+1850.654)/ 2 )
=735.153/1798.498
=40.88 %

Sunmax Biotechnology Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=1763.408/( (1850.654+2306.09)/ 2 )
=1763.408/2078.372
=84.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2025) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Sunmax Biotechnology Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Sunmax Biotechnology Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sunmax Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
Huandong Road, New Urban District, 1st Floor, No. 10, Lane 31, Section 1, Tainan Science Industrial Park, Tainan, TWN
Sunmax Biotechnology Co Ltd is a biomedical company in Taiwan. It is engaged in the development, manufacturing, and commercialization of Sunmax medical devices and bio-surgical products. Additionally, it also researches, develops, manufactures and sales biomedical material grade collagen and related products. The company's products include medical products, biomedical materials, and porcine collagen skin care products.

Sunmax Biotechnology Co Headlines

No Headlines